Secondary prevention: Benefits extend to elderly A contemporary study following elderly MI patients has shown improvements in mortality over a decade, with around a 3% reduction in deaths per year. The results are probably due to increased use of cardiovascular medications and should encourage doctors to make sure they apply evidence-based interventions to all eligible patients, say the researchers. (Setoguchi S et al. J Am Coll Cardiol 2008; 51:1247-1254.)
To view the full text of this article, you must be logged in as a registered member.
HeartBeat
